Cloudiness or visible particles indicate contamination or precipitation
If you have NASH without diabetes or obesity, approval requires submitting a prior authorization with: Biopsy or imaging confirmation of NASH with fibrosis stage F2 or higher Documentation of failed standard treatments (vitamin E, pioglitazone, lifestyle modification for at least 6 months) Peer-reviewed evidence supporting GLP-1 use in NASH A letter of medical necessity from a hepatologist or gastroenterologist Approval rate: 15-25% on first submission, 30-40% after appeal with additional specialist documentation
Saxenda specifically licensed for weight management) [2] [5] Dulaglutide (Trulicity for diabetes only) Exenatide (Byetta, Bydureon for diabetes only) Oral semaglutide (Rybelsus for diabetes only) These medications are administered via subcutaneous injection (except Rybelsus), with dosing frequencies ranging from daily to weekly depending on the specific formulation
The amount of weight lost before plateauing and the timing of the plateau differ among individuals, influenced by genetics, baseline weight, medication dose, and lifestyle factors
They are interconnected aspects of the same system
For someone considering long-term supplement use, comparing to surgical options becomes relevant